Gut Microbiota in Hypertension and Atherosclerosis: A Review

Barbara J. H. Verhaar(Amsterdam Neuroscience), Majon Muller(Amsterdam University Medical Centers), Max Nieuwdorp(Amsterdam Institute for Addiction Research), Andrei Prodan(AstraZeneca (Netherlands))
Nutrients
September 29, 2020
10.3390/nu12102982
Cited by 395

Related Papers

Microbially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
|Cell|2018|820
Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography
|Nature Medicine|2018|750
Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing
|PLoS ONE|2020|474
Gut microbiome-wide association study of depressive symptoms
|Nature Communications|2022|437
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial
|Gut|2020|312